You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

P-D1

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Retinal Deep PhenotypingTM

Recruiting
  • Healthy
    • Waterloo, Ontario, Canada
    • +2 more
    Jun 16, 2023

    Healthy Volunteers, Type 2 Diabetes Trial in Overland Park (Semaglutide D Dose 1, Semaglutide D Dose 2, Semaglutide D Dose 3)

    Active, not recruiting
    • Healthy Volunteers
    • Type 2 Diabetes
    • Semaglutide D Dose 1
    • +5 more
    • Cypress, California
    • +2 more
    Dec 27, 2022

    P0.1 and Extubation Failure in Critically Ill Patients

    Not yet recruiting
    • Weaning Failure
    • +2 more
    • Reintubation
    • Amiens, France
    • +2 more
    Mar 25, 2023

    Pancreatic Ductal Adenocarcinoma, Colorectal Cancer, NSCLC Trial (ELI-002 7P)

    Not yet recruiting
    • Pancreatic Ductal Adenocarcinoma
    • +14 more
    • ELI-002 7P
    • (no location specified)
    Feb 3, 2023

    KRAS P.G12C Trial in Worldwide (D3S-001)

    Recruiting
    • KRAS P.G12C
    • Detroit, Michigan
    • +12 more
    Jan 16, 2023

    Electronic Cigarette Use, Retina; Change Trial in Montréal (RETI-port/scan 21, Zilia Ocular, OCT-A)

    Recruiting
    • Electronic Cigarette Use
    • Retina; Change
    • RETI-port/scan 21
    • +2 more
    • Montréal, Quebec, Canada
      École d'optométrie de l'Université de Montréal
    Apr 3, 2023

    enVista Toric 0.9D Intraocular Lenses

    Recruiting
    • Corneal Astigmatism
    • enVista Toric
    • enVista non-Toric (spherical)
    • Calgary, Alberta, Canada
    • +2 more
    Nov 9, 2022

    Asthma Trial in Canada (Vitamin D, Placebo)

    Recruiting
    • Asthma
    • Vitamin D
    • Placebo
    • Vancouver, British Columbia, Canada
    • +8 more
    Jan 30, 2023

    Long-Term Development of Muscular Dystrophy Outcome Assessments

    Not yet recruiting
    • LGMD1A
    • +33 more
      • Richmond, Virginia
        Virginia Commonwealth University
      Aug 3, 2023

      Smoking, Tobacco Use Trial in High Point (ENDS Product A with 1.5% nicotine, ENDS Product B with 1.5% nicotine, ENDS Product C

      Completed
      • Smoking
      • Tobacco Use
      • ENDS Product A with 1.5% nicotine
      • +7 more
      • High Point, North Carolina
        High Point Clinical Trials Center
      Jun 23, 2022

      People Who Have Genetic Changes and Features of Autism: Simons

      Recruiting
      • 16P11.2 Deletion Syndrome
      • +184 more
        • New York, New York
        • +1 more
        Jan 6, 2023

        Acute Bilineal Leukemia, Acute Biphenotypic Leukemia, Acute Leukemia of Ambiguous Lineage Trial in Houston (Clofarabine,

        Recruiting
        • Acute Bilineal Leukemia
        • +7 more
        • Houston, Texas
          M D Anderson Cancer Center
        Aug 18, 2022

        ENSAT Stage I Adrenal Cortex Carcinoma, ENSAT Stage II Adrenal Cortex Carcinoma, ENSAT Stage III Adrenal Cortex Carcinoma Trial

        Recruiting
        • ENSAT Stage I Adrenal Cortex Carcinoma
        • +2 more
        • Ann Arbor, Michigan
        • +3 more
        Dec 13, 2022

        Recurrent B Acute Lymphoblastic Leukemia, Recurrent T Acute Lymphoblastic Leukemia, Refractory B Acute Lymphoblastic Leukemia

        Recruiting
        • Recurrent B Acute Lymphoblastic Leukemia
        • +3 more
        • Houston, Texas
          M D Anderson Cancer Center
        Nov 2, 2022

        HIV-1-infection Trial in United States (GS-5894, B/F/TAF, Standard of Care)

        Recruiting
        • HIV-1-infection
        • Los Angeles, California
        • +15 more
        Jan 13, 2023

        Hematopoietic and Lymphoid Cell Tumor, Recurrent Acute Lymphoblastic Leukemia, Recurrent Acute Myeloid Leukemia Trial in Houston

        Active, not recruiting
        • Hematopoietic and Lymphoid Cell Neoplasm
        • +8 more
        • Houston, Texas
          M D Anderson Cancer Center
        Oct 6, 2022

        Mantle Cell Lymphoma Trial in United States (Acalabrutinib, Bortezomib, Cyclophosphamide)

        Recruiting
        • Mantle Cell Lymphoma
        • New Orleans, Louisiana
        • +5 more
        Dec 13, 2022

        Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome

        Active, not recruiting
        • Acute Lymphoblastic Leukemia
        • +15 more
        • Laboratory Biomarker Analysis
        • +3 more
        • Chicago, Illinois
        • +2 more
        Jan 12, 2023

        Autism Spectrum Disorder Trial in Worldwide (GWP42003-P, Placebo)

        Recruiting
        • Autism Spectrum Disorder
        • Phoenix, Arizona
        • +15 more
        Jul 28, 2022

        Chronic Hepatitis B Infection, Chronic Hepatitis D Infection Trial in Taipei City, Taipei city, Taoyuan city (P1101 + Nivolumab

        Recruiting
        • Chronic Hepatitis B Infection
        • Chronic Hepatitis D Infection
        • P1101 + Nivolumab + Entecavir
        • Taipei City, Taiwan
        • +3 more
        Sep 15, 2021

        Switch to Lurasidone in Subjects With Schizophrenia"

        Recruiting
        • Schizophrenia
        • Lurasidone
        • aripiprazole, olanzapine, quetiapine or risperidone
        • Ancona, AN, Italy
        • +14 more
        Jul 19, 2022

        SARSCoV2 (COVID-19) Vaccination in Type 1 Diabetes (CoVaxT1D)

        Active, not recruiting
        • Type 1 Diabetes
        • blood test
        • Milan, MI, Italy
          ASST FBF-Sacco P.O. Sacco
        Sep 27, 2021

        Philadelphia Chromosome Negative, Recurrent B Acute Lymphoblastic Leukemia, Refractory B Acute Lymphoblastic Leukemia Trial in

        Terminated
        Has Results
        • Philadelphia Chromosome Negative
        • +2 more
        • Blinatumomab
        • +11 more
        • Houston, Texas
          M D Anderson Cancer Center
        Nov 3, 2022

        Liver Cirrhosis Trial (Caffeine, Warfarin sodium, Omeprazole)

        Not yet recruiting
        • Liver Cirrhosis
        • (no location specified)
        Feb 14, 2023

        Elagolix For the Treatment of Endometriosis in Canada

        Completed
        • Endometriosis
          • Calgary, Alberta, Canada
          • +17 more
          Sep 26, 2022